Seer, Inc.
Tracked across 2 events · 12 articles · First seen May 29, 2026 · Last active Jul 02, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Seer, Inc. is the primary complainant in the patent infringement cases, seeking to protect its intellectual property related to nanoparticle protein enrichment technology. The favorable decisions from the International — European Patent Office and the U.S. International Trade Commission strengthen its market position and intellectual property portfolio.
Jul 01, 2026 · 6 articles
Business
Impact: Seer received an unsolicited acquisition proposal from its Chair and CEO, Omid Farokhzad, M.D., which could lead to its acquisition or other strategic alternatives. The company's Board of Directors will establish a Special Committee to evaluate the proposal.
Jul 02, 2026 · 6 articles
100
Omid Farokhzad proposed to acquire Seer, Inc.Omid Farokhzad proposes...
95
Seer, Inc. received proposal Omid FarokhzadOmid Farokhzad proposes...
80
Seer, Inc. will establishOmid Farokhzad proposes...
80
International — European Patent Office maintained patent Seer, Inc.Seer Wins European Patent,...
70
Seer, Inc. filed complaint United States — United States International Trade CommissionSeer Wins European Patent,...
60
Seer, Inc. filed complaint Nanomics Biotechnology CompanySeer Wins European Patent,...
ERGEN INTELLIGENCE
Track Seer, Inc. live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard